Revolution Medicines Inc

RVMD · NASDAQ

Biological Product (except Diagnostic) Manufacturing

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit high-value frontier targets in RAS-addicted cancers. The company possesses sophisticated structure-based drug discovery capabilities built upon deep chemical biology and cancer pharmacology know-how and innovative, proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites.

ESG Scores

Overall ESG

3.9

Environmental

6.6

Social

3.6

Governance

4.8

Gender Diversity

Female Directors0.3333%

Female Executives0.15789473684210525%

CEO GenderMale

Market Data

Price$196.55+14.40 (+7.91%)

Market Cap$42.14B

P/E Ratio—

EPS$—

52W High$224.31

52W Low$52.40

Beta1.43